HK1074801A1 - Transdermal delivery system of gestodene - Google Patents

Transdermal delivery system of gestodene

Info

Publication number
HK1074801A1
HK1074801A1 HK05108895.4A HK05108895A HK1074801A1 HK 1074801 A1 HK1074801 A1 HK 1074801A1 HK 05108895 A HK05108895 A HK 05108895A HK 1074801 A1 HK1074801 A1 HK 1074801A1
Authority
HK
Hong Kong
Prior art keywords
gestodene
delivery system
transdermal delivery
transdermal
delivery
Prior art date
Application number
HK05108895.4A
Other languages
English (en)
Inventor
Thomas Langguth
Stefan Bracht
Michael Dittgen
Petra Huber
Drik Schenk
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1074801(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of HK1074801A1 publication Critical patent/HK1074801A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK05108895.4A 2003-12-12 2005-10-07 Transdermal delivery system of gestodene HK1074801A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03078881 2003-12-12

Publications (1)

Publication Number Publication Date
HK1074801A1 true HK1074801A1 (en) 2005-11-25

Family

ID=34924031

Family Applications (2)

Application Number Title Priority Date Filing Date
HK05108895.4A HK1074801A1 (en) 2003-12-12 2005-10-07 Transdermal delivery system of gestodene
HK10100292.3A HK1132682A1 (en) 2003-12-12 2010-01-12 Transdermal delivery system of hormones without penetration enhancers

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK10100292.3A HK1132682A1 (en) 2003-12-12 2010-01-12 Transdermal delivery system of hormones without penetration enhancers

Country Status (24)

Country Link
EP (2) EP1541137B1 (es)
CN (1) CN101843603B (es)
AR (1) AR046762A1 (es)
AT (1) ATE457168T1 (es)
CR (1) CR8465A (es)
CY (2) CY1110637T1 (es)
DE (1) DE602004025444D1 (es)
DK (2) DK2138169T3 (es)
ES (2) ES2340925T3 (es)
GT (1) GT200400262A (es)
HK (2) HK1074801A1 (es)
HN (1) HN2004000526A (es)
HR (2) HRP20100254T1 (es)
JO (1) JO2606B1 (es)
ME (1) ME01069B (es)
MY (2) MY144053A (es)
PE (1) PE20051035A1 (es)
PL (2) PL1541137T3 (es)
PT (2) PT1541137E (es)
RS (2) RS51260B (es)
SI (2) SI1541137T1 (es)
SV (1) SV2006001970A (es)
TW (1) TWI257299B (es)
UA (1) UA89766C2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL219030B1 (pl) 2003-02-21 2015-03-31 Schering Ag Transdermalny system terapeutyczny w postaci plastra odporny na działanie promieniowania UV
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
CA2740002C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
CA2740005C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
EP2343964A4 (en) 2008-10-08 2012-11-07 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
US9198920B2 (en) 2009-03-27 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
PT2613772T (pt) 2010-09-06 2017-03-06 Bayer Ip Gmbh Emplastros transdérmicos de dose baixa com alta libertação de fármaco
US20130195956A1 (en) * 2012-01-27 2013-08-01 Agile Therapeutics, Inc. Transdermal Hormone Delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081537A (en) 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
EP0573133A1 (de) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Mittel zur transdermalen Applikation das Gestoden enthält
AU657502B2 (en) 1990-10-29 1995-03-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4329242A1 (de) * 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
DE60043621D1 (de) 1999-11-24 2010-02-11 Agile Therapeutics Inc Verbessertes transdermales verabreichungssystem zur empfängnisverhütung und verfahren
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
TWI287455B (en) * 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use

Also Published As

Publication number Publication date
AR046762A1 (es) 2005-12-21
JO2606B1 (en) 2011-11-01
RS53182B (en) 2014-06-30
HK1132682A1 (en) 2010-03-05
ME01069B (me) 2012-10-20
PT1541137E (pt) 2010-05-17
PL1541137T3 (pl) 2010-07-30
HRP20100254T1 (hr) 2010-06-30
MY144053A (en) 2011-08-15
ES2340925T3 (es) 2010-06-11
SI1541137T1 (sl) 2010-06-30
CY1115064T1 (el) 2016-12-14
TWI257299B (en) 2006-07-01
SV2006001970A (es) 2006-02-16
TW200528073A (en) 2005-09-01
EP2138169A3 (en) 2011-04-06
EP2138169A2 (en) 2009-12-30
HRP20140077T1 (hr) 2014-02-28
EP1541137B1 (en) 2010-02-10
EP1541137A3 (en) 2005-11-16
CN101843603B (zh) 2012-06-27
CR8465A (es) 2007-06-06
UA89766C2 (en) 2010-03-10
DK1541137T3 (da) 2010-04-26
EP1541137A2 (en) 2005-06-15
ES2445690T3 (es) 2014-03-04
DE602004025444D1 (de) 2010-03-25
CN101843603A (zh) 2010-09-29
RS51260B (sr) 2010-12-31
MY152750A (en) 2014-11-28
PT2138169E (pt) 2014-02-17
EP2138169B1 (en) 2013-11-06
HN2004000526A (es) 2010-02-01
ATE457168T1 (de) 2010-02-15
PE20051035A1 (es) 2006-02-08
DK2138169T3 (da) 2013-11-18
CY1110637T1 (el) 2015-04-29
GT200400262A (es) 2005-10-31
SI2138169T1 (sl) 2014-03-31
PL2138169T3 (pl) 2014-04-30

Similar Documents

Publication Publication Date Title
HK1074801A1 (en) Transdermal delivery system of gestodene
IL173152A0 (en) Transdermal hormone delivery system: compositions and methods
EP1720605A4 (en) TRANSDERMAL DELIVERY SYSTEM FOR COSMETIC AGENTS
PL1631255T3 (pl) System dostarczania leków
IL174894A0 (en) Transdermal drug delivery device
EP1802258A4 (en) BIOSYNCHRONE TRANSDERMAL MEDICINES
IL175878A0 (en) Transdermal system for sustained delivery of polypeptides
HK1084590A1 (en) Pharmaceutical composition for transdermal or transmucosal administration
AU2003221770A8 (en) Controlled release transdermal drug delivery
IL174690A0 (en) Enhanced drug delivery
HUP0303313D0 (en) Transdermal pharmaceutical compositions
GB0218126D0 (en) Drug delivery system
HK1085394A1 (en) Uv stable transdermal therapeutic plaster
EP1750677A4 (en) ORAL ADMINISTRATION SYSTEM OF THERAPEUTIC COMPOUND
EP1450876A4 (en) INTEGRATED TRANSDERMAL DRUG DELIVERY SYSTEM
EP1667619A4 (en) PHARMACEUTICAL FEEDING SYSTEM
AU2003212962A8 (en) Transdermal drug delivery systems
AU2003241134A1 (en) Transdermal drug delivery system
AU2002329530A1 (en) Transdermal delivery system
GB0327814D0 (en) Aerosolisable composition and delivery system
GB0401008D0 (en) Drug delivery system
GB0214012D0 (en) Transdermal delivery system
IL172686A0 (en) Transdermal delivery system for cosmetic agents
AU2003906243A0 (en) Transdermal delivery system
GB2410485B (en) Medicament delivery system

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211210